Successful immunoglobulin treatment in a patient with neuromyotonia

Clin Neurol Neurosurg. 2000 Sep;102(3):173-5. doi: 10.1016/s0303-8467(00)00093-7.

Abstract

Neuromyotonia is characterized by spontaneous and continuous muscle fibre activity leading to muscle cramps, pseudomyotonia, myokymia and weakness. Electromyographic recordings show typical findings. An auto-immune mechanism has been suggested in at least a subset of patients. Various therapies have been tried with different outcome. A patient with neuromyotonia responding well to high-dose immunoglobulin treatment is presented.

Publication types

  • Case Reports

MeSH terms

  • Autoimmunity
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Electromyography
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage
  • Immunoglobulins, Intravenous / therapeutic use*
  • Isaacs Syndrome / drug therapy*
  • Isaacs Syndrome / etiology
  • Isaacs Syndrome / immunology
  • Isaacs Syndrome / physiopathology
  • Male
  • Middle Aged
  • Polyneuropathies / complications
  • Remission Induction

Substances

  • Immunoglobulins, Intravenous